Journals / ARTEMİS / 2004 / Cilt: 5 - Sayı: 2

Normal tekil gebeliği komplike eden spontan ovaryan hiperstimülasyon sendromu: Olgu sunumu

Spontaneous ovarian hyperstimulation syndrome complicating a normal singleton pregnancy: A case report

Journal
ARTEMİS
Pages
156–158
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When abdominal distension and dyspnea progressed, leading to deleterious laboratory results, the pregnancy was terminated by therapeutic abortion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ovarian hyperstimulation syndrome (OHSS) is the most common and sometimes life threatening complication of ovulation induction protocols and assisted reproductive procedures.
📊
Key Findings & Data:It usually occurs iatrogenically by the use of drugs such as exogenous gonadotropins or less frequently colmiphene citrate to induce multiple ovulation.
💡
Conclusion & Impact:When abdominal distension and dyspnea progressed, leading to deleterious laboratory results, the pregnancy was terminated by therapeutic abortion.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Ovarian hyperstimulation syndrome (OHSS) is the most common and sometimes life threatening complication of ovulation induction protocols and assisted reproductive procedures. It usually occurs iatrogenically by the use of drugs such as exogenous gonadotropins or less frequently colmiphene citrate to induce multiple ovulation. However spontaneous form of this syndrome is extremely rare in the literature. In this report we describe a case of spontaneous OHSS that occurred in a 26 year old pregnant woman with no underlying disease. When abdominal distension and dyspnea progressed, leading to deleterious laboratory results, the pregnancy was terminated by therapeutic abortion.

Özet

Ovaryan hiperstimülasyon sendromu (OHSS), ovulasyon indüksiyon protokolleri ve assiste reprodütif prosedürlerin en sık gözlenen ve bazen de hayatı tehdit edebilen bir komplikasyonudur. Çoğu kez multipl ovulasyon elde etmek amacıyla ekzojen gonadotropinler ve daha nadir olarak da klomifen sitrat gibi ajanların kullanılmasına bağlı, iyatrojenik olarak gelişen bir sendromdur. Bununla beraber bu sendromun spontan formu oldukça nadirdir. Bu makalede altta yatan herhangi bir hastalığı bulunmayan, 26 yaşındaki gebede spontan olarak gelişen ovaryan hiperstimülasyon sendromu sunulmuştur. Abdominal distansiyon, dispne ve laboratuvar bulgularındaki kötüleşme nedeniyle gebelik terapötik abortusla sonlandırılmıştır.

🔖

Cite This Article

AKERCAN, F., KARADADAŞ, N., ULUKUŞ, M., YENİEL, Ö., ULUKUŞ, M. (2022). Normal tekil gebeliği komplike eden spontan ovaryan hiperstimülasyon sendromu: Olgu sunumu. ARTEMİS, Cilt: 5 - Sayı: 2, 156–158. https://ajindex.com/articles/449479

References (14)

  1. Tucker TE. Reproductive toxicity of ovulation induction. Semin Reprod Endocrinol 1996;14:345-353
  2. Delvigne A and Rosenberg S. Systematic review of data concerning etiopathology of ovarian hyperstimulation syndrome. Int J Fertil Womens Med 2002;47:211-226
  3. Foong LC, Bhagavath B, Kumar J and Ng SC. Ovarian hyperstimulation syndrome is associated with reversible impairment of vascular reactivity. Fertil Steril 2002;78:1159-1163
  4. Schenker JG. Clinical aspects of ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 1999;85:13-20
  5. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z and Caspi E. Ovari- an hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989;44:430-440
  6. Rutkowski A. and Dubinsky I. Ovarian hyperstimulation syndrome: imperatives for the imergency physician. J Emerg Med 1999;17:669-672
  7. Abramov Y, Schenker JG, Levin A, Friedler S, Nisman B and Barak V. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod 1996;11:1381-1386
  8. Loret de Mola JR, Flores JP, Baumgardner GP, Goldfarb JM, Gindlesperger V and Friedlander MA. Elevated interleukin-6 levels in the ovarian hyperstimulation syndrome: ovarian immunhistochemical localization of interleukin-6 signal. Obstet Gynecol 1996;87:581-587
  9. Delbaere A, Bergmann PJ, Gervy-Decoster C, Deschodt-Lanckman M, de Maertelaer V, Staroukine M, Camus M and Englert Y. Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation. Fertil Steril 1997;67:1038-1045
  10. Abramov Y, Barak V, Nisman B and Schenker JG. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 1997;67: 261-265
  11. Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ and Yeo KT. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 1996;65:552-555
  12. Ludwig M, Bauer O, Lopens A, Jelkmann W and Diedrich K. Serum concentrations of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome. Hum Reprod 1998;13: 30-32
  13. Zalel Y, Katz Z, Caspi B, Ben-Hur H, Dgani R and Insler V. Spontaneous ovarian hyperstimulation syndrome concomitant with spontaneous pregnancy in a woman with polycystic ovary disease. Am J Obstet Gynecol 1992;167:122-124
  14. Zalel Y, Orvieto R,